Company / Current Assets per Share
Cullinan Therapeutics, Inc. Current Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.09
FY2024
5-year range
$7.09 / $11.56
FY2020-FY2024
Trend
-38.7%
vs FY2023
Sector context
#103 of 210
Health Care
What the data says
At $7.09, Cullinan Therapeutics, Inc.'s current assets per share ranks #103 of 210 in the Health Care sector. Declined from $10.36 to $7.09 over the past 2 years.
Based on SEC 10-K filings.
7.09 in FY2024 with a 3-year CAGR of -10.7%.
Declined from $10.36 to $7.09 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 210 in Health CareTop 49% of 210This company $7.09 Sector average $170.68
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2024, current assets per share decreased 38.7% year-over-year.
- Ranks #103 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.09 | -38.7% |
| FY2023 | $11.56 | +11.5% |
| FY2022 | $10.36 | +4.2% |
| FY2021 | $9.94 | -6.9% |
| FY2020 | $10.67 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026